{"schema_version":"secwatch.filing_event.v1","accession":"0001493152-24-040599","form_type":"8-K","ticker":"AIXC","cik":"0001460702","company_name":"AIxCrypto Holdings, Inc.","filed_at":"2024-10-09T23:59:59+00:00","discovered_at":"2026-05-14T18:03:08.491172+00:00","generated_at":"2026-05-30T17:13:23.118507+00:00","sec_items":["5.02","8.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.3,"calibrated_materiality_score":0.3,"confidence":"high","headline":"Qualigen Therapeutics adds Braeden Lichti to board; Robert Lim named audit chair; Korenberg resigns","bullets":["Matt Korenberg resigned director and audit chair Oct 3, 2024; no disagreement cited.","Braeden Lichti appointed independent director Oct 8, 2024; founder of BWL Investments and NorthStrive.","Robert Lim appointed as audit committee chairperson effective Oct 8, 2024.","Director agreement includes $5,000 monthly base fee, equity eligibility, and standard indemnification."],"urls":{"canonical":"https://secwatch.observer/filing/0001493152-24-040599","json":"https://secwatch.observer/filing/0001493152-24-040599.json","markdown":"https://secwatch.observer/filing/0001493152-24-040599.md","text":"https://secwatch.observer/filing/0001493152-24-040599.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-30T17:13:23.118507+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"5de1f83229","claim":"Braeden Lichti was appointed as Independent Director at AIxCrypto Holdings, Inc..","evidence_excerpt":"On October 8, 2024, the Board of Directors (the “Board”) appointed Braeden Lichti as an independent member of the Board, effective immediately, and approved the Director Agreement, attached hereto as Exhibit 10.1.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Independent Director"}],"fact_type":"executive_change"},{"claim_id":"b7fc05b45b","claim":"Matt Korenberg resigned as Independent Director and Chairman of Audit Committee at AIxCrypto Holdings, Inc..","evidence_excerpt":"On October 3, 2024, Mr. Matt Korenberg, independent member and chairman of the audit committee of the board of directors (the “Board”) of Qualigen Therapeutics, Inc. (the “Company”), tendered his resignation from all positions held with the Company, with such resignation becoming effective immediately.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1460702/000149315224040599/0001493152-24-040599-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"resigned"},{"label":"Role","value":"Independent Director and Chairman of Audit Committee"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}